Your portfolio is reporting progress.
That's not the same as delivering value.
Independent assurance that your technology programmes are delivering the EBITDA you underwrote.
You're getting reporting. Not the full picture.
Across portfolio companies, technology programmes report progress — often confidently. But:
- –Management teams are invested in the narrative
- –Vendors reinforce positive signals
- –Issues surface only when they're material
- –By then, value has already eroded
- ✓It isn't what you're told
- ✓It's what you're not seeing
- ✓Narrative confidence isn't the same as delivery evidence
- ✓By the time it's visible in reporting, the window to act has often closed
What every operating partner actually needs answered
Are we going to hit the number?
Is this actually delivering the EBITDA uplift we underwrote?
Where is the downside?
What could erode value — and how exposed are we?
Is this real, or management optimism?
Can we trust what we're being told?
Whether your investment is translating into results — not just progress
No reliance on internal reporting. No delivery bias.
Different moments, different questions
| Situation | What you need to know | What we provide | Typical investment |
|---|---|---|---|
| Something feels off | Is this delivering the value we underwrote? Where is the downside? | Independent view of value delivery, downside risk, and what needs to change | £30k–£60k |
| Post-acquisition | What did we actually buy? Where are the hidden risks? | Rapid diagnostic of delivery, risk exposure, and alignment to the investment case | £20k–£40k |
| Pre-exit | Will this stand up in diligence? Are there gaps in the value story? | Independent validation of transformation outcomes, key risks, and areas to address before exit | £50k–£100k+ |
| Across the portfolio | Where should we intervene? Where is value at risk? | Cross-portfolio visibility to prioritise action, focus management attention, and improve capital allocation | £75k–£150k+ |
For portfolios where a one-off review isn't enough
Standing coverage, not just a single point-in-time check.
Standing coverage across your portfolio
- Recurring, independent read across priority portfolio companies
- Delivered ahead of each portfolio company's board meeting, not on a separate calendar
- Consistent scoring across companies, so risk is comparable — not just reported
- Built for operating partners tracking 3+ companies at once
A standing product, not a one-off engagement — pricing reflects ongoing coverage, not a single report.
Same rigour. A fraction of the cost and time.
| Traditional assurance | Performance Radar | |
|---|---|---|
| Cost | £250k–£500k+ engagements | From £20k |
| Timeline | 8–12 weeks | ~2 weeks |
| Team | Large teams | Lean, focused |
| Reporting | Extensive reporting | Executive-level output |
| Delivery stance | Embedded in delivery | Fully independent |
| Orientation | Retrospective reporting | Early signal, forward-looking |
Structured, decision-ready output — no long reports, no noise
Where value is at risk
Clear view of downside exposure across the programme.
What is driving underperformance
The root causes behind missed outcomes and delay.
Whether the programme will deliver the value underwritten
Independent assessment of delivery against the value creation plan.
What needs to change now
Specific, actionable interventions for management and sponsors.
A concise executive readout
Structured, decision-ready output — no long reports, no noise.
Assessed across portfolio companies under real transaction pressure
"Gave us an independent view of where we stood ahead of a potential transaction — completed in weeks."CIO, European Commodity Trader
Understand whether your portfolio is delivering the value you paid for — and where to act.
No obligation, no sales pitch — just a conversation about whether it's the right moment to bring in an independent read.